Kimia Bioscien.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE285U01025
  • NSEID:
  • BSEID: 530313
INR
30.41
-0.66 (-2.12%)
BSENSE

Nov 20

BSE+NSE Vol: 1.32 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 263659,
    "name": "Kimia Bioscien.",
    "stock_name": "Kimia Bioscien.",
    "full_name": "Kimia Biosciences Ltd",
    "name_url": "stocks-analysis/kimia-bioscien",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "30.41",
    "chg": -0.66,
    "chgp": "-2.12%",
    "dir": -1,
    "prev_price": "31.07",
    "mcapval": "152.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530313,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE285U01025",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "1.32 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/kimia-bioscien-263659-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Kimia Biosciences Ltd Valuation Shifts to Very Attractive Amid Sector Challenges",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/kimia-biosciences-ltd-valuation-shifts-to-very-attractive-amid-sector-challenges-4265799",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/KimiaBioscience_valuationdot_4265799.png",
        "date": "2026-11-18 08:00:55",
        "description": "Kimia Biosciences Ltd has witnessed a marked improvement in its valuation parameters, shifting from an attractive to a very attractive rating. This change reflects a significant recalibration in price-to-earnings and price-to-book value metrics, positioning the micro-cap pharmaceutical firm favourably against its peers and historical benchmarks."
      },
      {
        "title": "Kimia Biosciences Ltd Upgraded to Hold as Financial and Technical Trends Improve",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/kimia-biosciences-ltd-upgraded-to-hold-as-financial-and-technical-trends-improve-4264744",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/KimiaBioscience_mojoScore_4264744.png",
        "date": "2026-11-17 08:12:55",
        "description": "Kimia Biosciences Ltd has seen its investment rating upgraded from Sell to Hold following a notable improvement in its financial trend and technical indicators. Despite persistent challenges in sales growth and cash flow, the company’s profitability and valuation metrics have strengthened, prompting a reassessment of its outlook within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Kimia Biosciences Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/kimia-biosciences-ltd-is-rated-strong-sell-4244607",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/KimiaBioscience_mojoScore_4244607.png",
        "date": "2026-10-30 10:10:24",
        "description": "Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 27 July 2026, reflecting a reassessment of the company’s outlook. However, all fundamentals, returns, and financial metrics discussed here are based on the stock’s current position as of 30 October 2026, providing investors with the most up-to-date analysis."
      },
      {
        "title": "Kimia Biosciences Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/kimia-biosciences-ltd-is-rated-strong-sell-4230187",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/KimiaBioscience_mojoScore_4230187.png",
        "date": "2026-10-19 10:10:22",
        "description": "Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 27 July 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 19 October 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Kimia Biosciences Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/kimia-biosciences-ltd-is-rated-strong-sell-4218800",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/KimiaBioscience_mojoScore_4218800.png",
        "date": "2026-10-08 10:10:27",
        "description": "Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 27 July 2026, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 08 October 2026, providing investors with the latest perspective on the company’s position."
      },
      {
        "title": "Kimia Biosciences Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/kimia-biosciences-ltd-is-rated-strong-sell-4206421",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KimiaBioscience_mojoScore_4206421.png",
        "date": "2026-09-27 10:10:16",
        "description": "Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 27 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 September 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Kimia Biosciences Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/kimia-biosciences-ltd-is-rated-strong-sell-4195017",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KimiaBioscience_mojoScore_4195017.png",
        "date": "2026-09-16 10:10:19",
        "description": "Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 27 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 16 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Kimia Biosciences Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/kimia-biosciences-ltd-is-rated-strong-sell-4177759",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KimiaBioscience_mojoScore_4177759.png",
        "date": "2026-09-01 10:10:26",
        "description": "Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 27 July 2026, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 01 September 2026, providing investors with the latest comprehensive view of the company’s position."
      }
    ],
    "total": 33,
    "sid": "263659",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/kimia-biosciences-263659"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Nov-2026",
      "details": "Newspaper publication of Unaudited financial results for the Quarter ended 30 September 2026",
      "source": "BSE"
    },
    {
      "caption": "Results-Unaudited Standalone Financial Result For Quarter Ending 30Th September 2026",
      "datetime": "13-Nov-2026",
      "details": "Unaudited Standalone Financial Results for second quarter and half year ended 30th September 2026 along with statement of assets and liabilities and cash flows and Limited Review Report thereon.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On November 13 2026 (Friday)",
      "datetime": "13-Nov-2026",
      "details": "Pursuant to Regulation 33 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we have enclosed herewith:",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

14-Nov-2026 | Source : BSE

Newspaper publication of Unaudited financial results for the Quarter ended 30 September 2026

Results-Unaudited Standalone Financial Result For Quarter Ending 30Th September 2026

13-Nov-2026 | Source : BSE

Unaudited Standalone Financial Results for second quarter and half year ended 30th September 2026 along with statement of assets and liabilities and cash flows and Limited Review Report thereon.

Board Meeting Outcome for Outcome Of Board Meeting Held On November 13 2026 (Friday)

13-Nov-2026 | Source : BSE

Pursuant to Regulation 33 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we have enclosed herewith:

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available